The drug "Encephabol". Instructions for use

The drug "Encephabol" refers to a class of neurotropic drugs that have a metabolic effect on the body. It is the representative of nootropics, which contain elements identical to the biologically active substances that make up the central nervous system of the human body. These components take part in the processes of metabolism occurring in the brain.

The "Encephabol" preparation, the instruction for the use of which describes the basic dosage forms, is manufactured by manufacturers in the form of tablets and suspensions. The main active substance of the agent is pyrithinol. This element is close in its chemical structure to pyridoxine, but its properties differ from vitamin B6 and have a specific effect. Encephabol (tablets) can be purchased in pharmacies in packages containing fifty or one hundred pieces, and the suspension in a bottle that has a volume of two hundred milliliters.

The drug has an action capable of activating processes aimed at the capture and utilization of glucose and the exchange of nucleic acids, as well as increase the release of acetylcholine in the synapses and increase the rate of cholinergic neuronal transmission. As a result, metabolic reactions in the brain are normalized. The Encefabol preparation, the instruction for its use explains its basic pharmacological properties, produces an action aimed at stabilizing the function of cell membranes, preventing the occurrence of free radicals. The drug increases the fluidity of the blood and the elasticity of red blood cells. Its reception helps to increase blood flow, increase oxygen consumption, and increase glucose metabolism in those parts of the brain that are prone to ischemic damage. Reception of the drug allows you to restore metabolic processes in the nervous tissues, increase mental performance and memory.

The Encephabol medicinal product, the instruction for its application, describes the mechanism of its effect on the body, has bioavailability, which on the average is equal to eighty-five percent. The drug binds to proteins that are in the blood plasma, ranging from twenty to forty percent. The maximum concentration of the drug is reached in thirty to sixty minutes after its administration. Metabolites formed in the liver are excreted with mucus masses and urine. Even if the kidney function is impaired, toxic concentrations of the drug in the body does not arise.

The Encephabol drug, whose instructions for use describe the main areas of its use, are recommended for the following ailments:

- dysfunction of the brain, which are chronic;

- Syndromes of dementia, expressed by disturbances of thinking and memory;

- increased fatigue;

- lack of motivation and motivation;

- affective disorders;

- reduced concentration of attention ;

- dementia of vascular, primary and mixed nature;

- mental impairment of a chronic nature;

- cerebral atherosclerosis ;

- post-traumatic encephalopathy ;

- impaired mental function;

- cerebrosthenic syndrome ;

- children's encephalopathy;

- consequences of encephalitis.

The administration of the drug may cause undesirable side effects in patients who are particularly sensitive to pyrithinol and fructose. No medication is prescribed for pathologies of the kidneys and liver, as well as autoimmune diseases of an acute nature.

Has the preparation "Encephabol" analogues, which are representatives of the nootropic class. These include the medicines "Nootropil", "Piriditol", "Pentoxifylline".